Cheng-Fang Yu

Statistics

Publications

Citations

845

H-Index

Active since

2004

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Cheng-Fang Yu is an author at Bristol-Myers Squibb (United States) specializing in infectious diseases, antiviral therapy, and antiviral drug resistance.

Publications per year

2004–2008

Publications

Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine

Daniel J. Tenney, Steven M. LeVine, R.E. Rose et al. · Antimicrobial Agents and Chemotherapy · 2004 · 538 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions Present

Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick et al. · Antimicrobial Agents and Chemotherapy · 2006 · 239 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response

Carl J. Baldick, Betsy J. Eggers, Jie Fang et al. · Journal of Hepatology · 2008 · 68 citations

Life Sciences, Infectious Diseases, Microbiology +15

1–3 of 3